QQQ   389.92 (-0.13%)
AAPL   194.17 (-0.05%)
MSFT   370.45 (-0.13%)
META   326.69 (+0.03%)
GOOGL   134.72 (-1.61%)
AMZN   145.97 (-0.62%)
TSLA   242.20 (-0.18%)
NVDA   469.57 (+0.77%)
NIO   7.52 (+0.40%)
BABA   72.30 (-0.04%)
AMD   127.74 (-0.49%)
T   17.00 (-0.53%)
F   10.92 (+0.92%)
MU   74.31 (+0.90%)
CGC   0.73 (+0.61%)
GE   119.83 (+0.29%)
DIS   92.79 (+0.48%)
AMC   6.86 (+0.59%)
PFE   28.79 (+0.56%)
PYPL   58.88 (+0.68%)
XOM   99.02 (+0.61%)
QQQ   389.92 (-0.13%)
AAPL   194.17 (-0.05%)
MSFT   370.45 (-0.13%)
META   326.69 (+0.03%)
GOOGL   134.72 (-1.61%)
AMZN   145.97 (-0.62%)
TSLA   242.20 (-0.18%)
NVDA   469.57 (+0.77%)
NIO   7.52 (+0.40%)
BABA   72.30 (-0.04%)
AMD   127.74 (-0.49%)
T   17.00 (-0.53%)
F   10.92 (+0.92%)
MU   74.31 (+0.90%)
CGC   0.73 (+0.61%)
GE   119.83 (+0.29%)
DIS   92.79 (+0.48%)
AMC   6.86 (+0.59%)
PFE   28.79 (+0.56%)
PYPL   58.88 (+0.68%)
XOM   99.02 (+0.61%)
QQQ   389.92 (-0.13%)
AAPL   194.17 (-0.05%)
MSFT   370.45 (-0.13%)
META   326.69 (+0.03%)
GOOGL   134.72 (-1.61%)
AMZN   145.97 (-0.62%)
TSLA   242.20 (-0.18%)
NVDA   469.57 (+0.77%)
NIO   7.52 (+0.40%)
BABA   72.30 (-0.04%)
AMD   127.74 (-0.49%)
T   17.00 (-0.53%)
F   10.92 (+0.92%)
MU   74.31 (+0.90%)
CGC   0.73 (+0.61%)
GE   119.83 (+0.29%)
DIS   92.79 (+0.48%)
AMC   6.86 (+0.59%)
PFE   28.79 (+0.56%)
PYPL   58.88 (+0.68%)
XOM   99.02 (+0.61%)
QQQ   389.92 (-0.13%)
AAPL   194.17 (-0.05%)
MSFT   370.45 (-0.13%)
META   326.69 (+0.03%)
GOOGL   134.72 (-1.61%)
AMZN   145.97 (-0.62%)
TSLA   242.20 (-0.18%)
NVDA   469.57 (+0.77%)
NIO   7.52 (+0.40%)
BABA   72.30 (-0.04%)
AMD   127.74 (-0.49%)
T   17.00 (-0.53%)
F   10.92 (+0.92%)
MU   74.31 (+0.90%)
CGC   0.73 (+0.61%)
GE   119.83 (+0.29%)
DIS   92.79 (+0.48%)
AMC   6.86 (+0.59%)
PFE   28.79 (+0.56%)
PYPL   58.88 (+0.68%)
XOM   99.02 (+0.61%)

Ventas Stock Price, News & Analysis (NYSE:VTR)

$46.39
+0.17 (+0.37%)
(As of 09:57 AM ET)
Compare
Today's Range
$46.02
$46.50
50-Day Range
$39.65
$47.18
52-Week Range
$39.33
$53.15
Volume
96,801 shs
Average Volume
2.19 million shs
Market Capitalization
$18.67 billion
P/E Ratio
4,643.64
Dividend Yield
3.88%
Price Target
$50.62

Ventas MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.73 Rating Score
Upside/​Downside
9.5% Upside
$50.62 Price Target
Short Interest
Healthy
1.84% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-2.06
Upright™ Environmental Score
News Sentiment
0.73mentions of Ventas in the last 14 days
Based on 8 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
7.02%
From $2.99 to $3.20 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.45 out of 5 stars

Finance Sector

195th out of 694 stocks

Real Estate Investment Trusts Industry

39th out of 144 stocks


VTR stock logo

About Ventas Stock (NYSE:VTR)

Ventas Inc., an S&P 500 company, operates at the intersection of two large and dynamic industries healthcare and real estate. Fueled by powerful demographic demand from growth in the aging population, Ventas owns or has investments in a highly diversified portfolio of approximately 1,400 properties in the United States, Canada, and the United Kingdom. Ventas uses the power of its capital to unlock the value of senior housing communities, outpatient medical buildings, research centers, hospitals and other healthcare facilities. A globally-recognized real estate investment trust, Ventas follows a successful long-term strategy, proven over more than 20 years, built on diversification of property types, capital sources and industry leading partners, financial strength and flexibility, consistent and reliable growth and industry leading ESG achievements, managed by a collaborative and experienced team dedicated to its stakeholders.

VTR Stock Price History

VTR Stock News Headlines

Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT?
A little-known metal called vanadium is vital to American national security and energy independence. But right now, China and Russia dominate our supply. The U.S. Govt. is so serious about vanadium, it funded and recently completed an "Earth MRI" survey to seek out new sources of this energy metal - in Wyoming.
Ventas Is Attractively Valued
Ventas Looks Ready To Return To Pre-COVID Highs
U.S. Military Defense Fails Without Vanadium?
The metal vanadium is needed for numerous military applications, including jet engines, airframes, and ballistic missiles. And although the U.S. Govt. considers vanadium critical to national security, less than 5% of the metal is mined in America. This means we're at the mercy of China and Russia for our supply.
Wedbush Upgrades Ventas (VTR)
Expert Ratings for Ventas
Ventas, Inc. (NYSE:VTR) Q3 2023 Earnings Call Transcript
The Ventas Inc (VTR) Company: A Short SWOT Analysis
Q3 2023 Ventas Inc Earnings Call
Ventas: Q3 Earnings Snapshot
Ventas Swings To Q3 Loss
Ventas Reports 2023 Third Quarter Results
Is a Beat in the Offing for Ventas (VTR) in Q3 Earnings?
See More Headlines
Receive VTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ventas and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/09/2023
Ex-Dividend for 10/12 Dividend
9/29/2023
Dividend Payable
10/12/2023
Today
12/08/2023
Ex-Dividend for 1/18 Dividend
12/29/2023
Fiscal Year End
12/31/2023
Dividend Payable
1/18/2024
Next Earnings (Estimated)
2/08/2024

Industry, Sector and Symbol

Industry
Real estate investment trusts
Sub-Industry
Specialized REITs
Sector
Finance
CUSIP
92276F10
Employees
451
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$50.62
High Stock Price Target
$55.00
Low Stock Price Target
$47.00
Potential Upside/Downside
+9.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.73
Research Coverage
11 Analysts

Profitability

Net Income
$-47,450,000.00
Pretax Margin
-1.95%

Debt

Sales & Book Value

Annual Sales
$4.38 billion
Cash Flow
$2.72 per share
Book Value
$25.57 per share

Miscellaneous

Free Float
398,357,000
Market Cap
$18.60 billion
Optionable
Optionable
Beta
1.25

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Should I Buy Ventas Stock? VTR Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Ventas was last updated on Tuesday, November 28, 2023 at 10:35 PM.

Pros

Here are some ways that investors could benefit from investing in Ventas, Inc.:

  • Ventas operates at the intersection of healthcare and real estate, two large and dynamic industries. This provides potential for growth and diversification.
  • The company owns or has investments in a highly diversified portfolio of approximately 1,400 properties in the United States, Canada, and the United Kingdom. This provides geographic diversification and potential for stable income streams.
  • Ventas focuses on senior housing communities, outpatient medical buildings, research centers, hospitals, and other healthcare facilities. These sectors have strong demographic demand due to the growth in the aging population.
  • Ventas is a globally-recognized real estate investment trust (REIT) with a successful long-term strategy. The company has a proven track record of consistent and reliable growth over more than 20 years.
  • Ventas has industry-leading partners, financial strength, and flexibility. This positions the company well for future opportunities and potential value creation.

Cons

Investors should be bearish about investing in Ventas, Inc. for these reasons:

  • The recent performance of the REIT Index, which declined 2.89%, may indicate potential challenges in the real estate investment trust sector.
  • The current stock price of Ventas, Inc. should be considered as part of the investment decision-making process. Please refer to the latest stock price for accurate information.
  • Investors should carefully evaluate the potential risks associated with the healthcare and real estate industries, including regulatory changes, market fluctuations, and economic conditions.
  • As with any investment, there is always a level of uncertainty and risk involved. Investors should conduct thorough research and analysis before making investment decisions.
  • Investors should consider their own investment goals, risk tolerance, and financial situation before investing in Ventas, Inc. It is important to align investments with individual circumstances and objectives.














VTR Stock Analysis - Frequently Asked Questions

Should I buy or sell Ventas stock right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ventas in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" VTR shares.
View VTR analyst ratings
or view top-rated stocks.

What is Ventas' stock price target for 2024?

11 equities research analysts have issued twelve-month price targets for Ventas' stock. Their VTR share price targets range from $47.00 to $55.00. On average, they predict the company's share price to reach $50.62 in the next twelve months. This suggests a possible upside of 9.5% from the stock's current price.
View analysts price targets for VTR
or view top-rated stocks among Wall Street analysts.

How have VTR shares performed in 2023?

Ventas' stock was trading at $45.05 at the beginning of the year. Since then, VTR stock has increased by 2.6% and is now trading at $46.22.
View the best growth stocks for 2023 here
.

When is Ventas' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 8th 2024.
View our VTR earnings forecast
.

How were Ventas' earnings last quarter?

Ventas, Inc. (NYSE:VTR) issued its quarterly earnings data on Thursday, February, 9th. The real estate investment trust reported ($0.11) EPS for the quarter, missing analysts' consensus estimates of $0.72 by $0.83. The real estate investment trust earned $1.05 billion during the quarter, compared to analyst estimates of $1.04 billion. Ventas had a trailing twelve-month return on equity of 0.05% and a net margin of 0.11%. The firm's revenue was up 2.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.73 earnings per share.
Read the conference call transcript
.

How often does Ventas pay dividends? What is the dividend yield for Ventas?

Ventas declared a quarterly dividend on Tuesday, December 5th. Investors of record on Tuesday, January 2nd will be paid a dividend of $0.45 per share on Thursday, January 18th. This represents a $1.80 annualized dividend and a dividend yield of 3.89%. The ex-dividend date is Friday, December 29th.
Read our dividend analysis for VTR
.

Is Ventas a good dividend stock?

Ventas (NYSE:VTR) pays an annual dividend of $1.80 per share and currently has a dividend yield of 3.85%. The dividend payout ratio is 18,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, VTR will have a dividend payout ratio of 56.25% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for VTR.

What guidance has Ventas issued on next quarter's earnings?

Ventas issued an update on its FY23 earnings guidance on Thursday, November, 2nd. The company provided earnings per share guidance of $2.96-2.99 for the period, compared to the consensus earnings per share estimate of $2.98.

What is Debra A. Cafaro's approval rating as Ventas' CEO?

20 employees have rated Ventas Chief Executive Officer Debra A. Cafaro on Glassdoor.com. Debra A. Cafaro has an approval rating of 89% among the company's employees.

What other stocks do shareholders of Ventas own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ventas investors own include AT&T (T), Verizon Communications (VZ), Realty Income (O), Coca-Cola (KO), Johnson & Johnson (JNJ), Enterprise Products Partners (EPD), Cisco Systems (CSCO), AbbVie (ABBV), Exxon Mobil (XOM) and Pfizer (PFE).

Who are Ventas' major shareholders?

Ventas' stock is owned by a number of retail and institutional investors. Top institutional investors include JPMorgan Chase & Co. (5.90%), FMR LLC (5.53%), Principal Financial Group Inc. (4.89%), Legal & General Group Plc (1.39%), Northern Trust Corp (1.32%) and Morgan Stanley (1.11%). Insiders that own company stock include Debra A Cafaro, Debra A Cafaro, Gregory R Liebbe, Richard I Gilchrist, Robert F Probst and Walter C Rakowich.
View institutional ownership trends
.

How do I buy shares of Ventas?

Shares of VTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:VTR) was last updated on 12/8/2023 by MarketBeat.com Staff

My Account -